Growth Metrics

Enanta Pharmaceuticals (ENTA) Enterprise Value Growth (1y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.31%
Dec 31, 2025 14.23%
Sep 30, 2025 23.90%
Jun 30, 2025 11.29%
Mar 31, 2025 35.61%
Dec 31, 2024 35.73%
Sep 30, 2024 -190.66%
Jun 30, 2024 40.48%
Mar 31, 2024 -42.95%
Dec 31, 2023 -57.20%
Sep 30, 2023 65.74%
Jun 30, 2023 -52.63%
Mar 31, 2023 25.06%
Dec 31, 2022 17.21%
Sep 30, 2022 -2.14%
Jun 30, 2022 1.38%
Mar 31, 2022 25.43%
Dec 31, 2021 32.92%
Sep 30, 2021 36.89%
Jun 30, 2021 30.59%
Mar 31, 2021 -5.82%
Dec 31, 2020 -3.32%
Sep 30, 2020 -15.34%
Jun 30, 2020 4.94%
Mar 31, 2020 4.03%
Dec 31, 2019 -8.10%
Sep 30, 2019 -8.59%
Jun 30, 2019 -42.46%
Mar 31, 2019 -44.19%
Dec 31, 2018 -56.86%
Sep 30, 2018 -38.03%
Jun 30, 2018 -42.29%
Mar 31, 2018 -46.22%
Dec 31, 2017 -5.29%
Sep 30, 2017 -6.47%
Jun 30, 2017 12.11%
Mar 31, 2017 20.35%
Dec 31, 2016 -16.40%
Sep 30, 2016 -44.84%
Jun 30, 2016 -41.77%
Mar 31, 2016 -33.21%
Dec 31, 2015 -72.90%
Sep 30, 2015 -60.16%
Jun 30, 2015 -60.71%
Mar 31, 2015 -74.60%
Dec 31, 2014 -13.20%
Sep 30, 2014 10.76%
Jun 30, 2014 -1.42%
Mar 31, 2014 13.14%
Dec 31, 2013 -343.19%
Sep 30, 2013 -131.89%
Jun 30, 2013 -2,286.92%
Mar 31, 2013 -427.06%